"Since the start of July 2023, the Company has submitted 62 Controlled
Correspondences, including 35 addressing potential new product candidates. In that period, the
Company has also had 27 other interactions with the FDA via video or teleconference, or as written
correspondence with the FDA."
That's more than 1 interaction a week. Hopefully we will get another approval soon.
Add to My Watchlist
What is My Watchlist?
